Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease
April 2013
Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease.
It's for patients with pituitary tumors...when surgery isn't an option or isn't effective.
It's an injectable somatostatin analogue that suppresses the release of ACTH (adrenocorticotropic hormone).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote